Cross-Clade Neutralizing Activity of Human Anti-V3 Monoclonal Antibodies Derived from the Cells of Individuals Infected with Non-B Clades of Human Immunodeficiency Virus Type 1
- 15 July 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (14), 6865-6872
- https://doi.org/10.1128/jvi.02202-05
Abstract
The majority of global human immunodeficiency virus infections are caused by viruses characterized by a GPGQ motif at the tip of the V3 loop. Characterization of anti-V3 monoclonal antibodies (MAbs) that neutralize isolates with the GPGQ V3 motif is an important step in designing vaccines that will induce such Abs. Consequently, seven human anti-V3 MAbs derived from the cells of individuals infected with non-B-subtype viruses (anti-V3non-BMAbs) were generated from the cells of individuals from Africa infected with circulating recombinant forms CRF02_AG, CRF09_cpx, and CRF13_cpx, each of which contains a subtype Aenvgene. Sequence analysis of plasma viruses revealed a GPGQ motif at the apex of the V3 loop from six of the seven subjects and a GPGR motif from one subject. The MAbs were selected with fusion proteins (FP) containing V392UG037.8or V3JR-CSFfrom subtype A or B, respectively. In virus binding assays, five of the seven (71%) anti-V3non-BMAbs bound to V3-FPs from both subtype A and subtype B, while only four of the nine (44%) anti-V3BMAbs recognized both V3-FPs. Using two neutralization assays, both the anti-V3non-Band the anti-V3BMAbs neutralized subtype B viruses with similar activities, while the anti-V3non-BMAbs exhibited a tendency toward both increased potency and breadth of neutralization against non-B viruses compared to anti-V3BMAbs. Statistical significance was not achieved, due in large measure to the sizes of the MAb panels, but the overall pattern of data strongly suggests that viruses with the GPGQ motif at the tip of the V3 loop induce anti-V3 Abs with broader cross-neutralizing activity than do viruses with the GPGR motif.Keywords
This publication has 39 references indexed in Scilit:
- Factors Determining the Breadth and Potency of Neutralization by V3-Specific Human Monoclonal Antibodies Derived from Subjects Infected with Clade A or Clade B Strains of Human Immunodeficiency Virus Type 1Journal of Virology, 2006
- Human Immunodeficiency Virus Type 1envClones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing AntibodiesJournal of Virology, 2005
- Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal AntibodiesJournal of Virology, 2004
- Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52DStructure, 2004
- Genetic and Biological Properties of HIV Type 1 Isolates Prevalent in Villagers of the Cameroon Equatorial Rain Forests and Grass Fields: Further Evidence of Broad HIV Type 1 Genetic DiversityAIDS Research and Human Retroviruses, 2003
- Antibody neutralization and escape by HIV-1Nature, 2003
- Alternative Conformations of HIV-1 V3 Loops Mimic β Hairpins in Chemokines, Suggesting a Mechanism for Coreceptor SelectivityStructure, 2003
- Identification and Characterization of a Peptide That Specifically Binds the Human, Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody b12Journal of Virology, 2001
- Vaccine-Elicited V3 Loop-Specific Antibodies in Rhesus Monkeys and Control of a Simian-Human Immunodeficiency Virus Expressing a Primary Patient Human Immunodeficiency Virus Type 1 Isolate EnvelopeJournal of Virology, 2001
- Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal AntibodyScience, 1994